fda warning bpc-157 peptide products unapproved not approved for human use Understanding the Legal Risks of and Other Peptides – Holt Law fda bpc-157 bpc – On Peptides, FDA Staff Scientists

One condition that may result is known as shoulder injury related to vaccine administration (SIRVA)

The FDA raised concerns about limited human trials, inconsistent chemical information, possible immune reactions and difficulty confirming the purity of finished products

Excipients such as sorbitol, mannitol (sugar alcohols), lactose (in those with intolerance), and various binding agents or fillers may contribute to gastrointestinal symptoms

With 476,857 individuals across 18 different countries (propensity score matched 1:1 with pregnant controls), this is the largest study to date in this historically underserved population

Disclaimer: This article is intended for licensed medical professionals